ArticleJournal of Korean medical science2010

Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.

Jung Sun Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.